Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome
暂无分享,去创建一个
Rui Gao | Pingying Qing | Chenyang Lu | Yi Liu | Xun Zeng | Xin Liao | Meng Cheng | Lang Qin
[1] Chengde Yang,et al. Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ , 2023, Annals of the Rheumatic Diseases.
[2] R. Levy,et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria , 2023, Arthritis & Rheumatology.
[3] J. Ernerudh,et al. The human placenta shapes the phenotype of decidual macrophages , 2022, bioRxiv.
[4] M. López-Hoyos,et al. Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis , 2022, Lupus.
[5] M. Tong,et al. Antiphospholipid Antibodies Increase Endometrial Stromal Cell Decidualization, Senescence, and Inflammation via Toll‐like Receptor 4, Reactive Oxygen Species, and p38 MAPK Signaling , 2022, Arthritis & rheumatology.
[6] M. Rojas,et al. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome , 2021, Frontiers in Physiology.
[7] F. Rubinstein,et al. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. , 2021, Thrombosis research.
[8] F. Petraglia,et al. Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta , 2021, Reproductive Sciences.
[9] Lisha Mou,et al. The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss , 2021, Frontiers in Immunology.
[10] Pengyun Qiao,et al. Uterine natural killer cells and recurrent spontaneous abortion , 2021, American journal of reproductive immunology.
[11] K. Qu,et al. Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss , 2021, Cell discovery.
[12] Q. Tu,et al. Single-cell Immune Landscape of Human Recurrent Miscarriage , 2021, Genom. Proteom. Bioinform..
[13] M. Du,et al. Functional regulation of decidual macrophages during pregnancy. , 2020, Journal of reproductive immunology.
[14] F. Beneventi,et al. Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies. , 2020, Rheumatology.
[15] J. Lieberman,et al. Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts , 2020, Cell.
[16] M. Pavlicev,et al. Endometrial Decidualization: The Primary Driver of Pregnancy Health , 2020, International journal of molecular sciences.
[17] Susumu Tanaka,et al. The transcription factor HAND2 up-regulates transcription of the IL15 gene in human endometrial stromal cells , 2020, The Journal of Biological Chemistry.
[18] J. Brosens,et al. Recurrent pregnancy loss is associated with a pro-senescent decidual response during the peri-implantation window , 2020, Communications Biology.
[19] B. Peng,et al. The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta‐analysis , 2019, Acta obstetricia et gynecologica Scandinavica.
[20] Liping Jin,et al. Dynamic Function and Composition Changes of Immune Cells During Normal and Pathological Pregnancy at the Maternal-Fetal Interface , 2019, Front. Immunol..
[21] W. Dean,et al. Mechanisms of early placental development in mouse and humans , 2019, Nature Reviews Genetics.
[22] A. Tincani,et al. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies , 2019, Front. Immunol..
[23] M. Ward,et al. EULAR recommendations for the management of antiphospholipid syndrome in adults , 2019, Annals of the rheumatic diseases.
[24] K. McCrae,et al. Complement in the Pathophysiology of the Antiphospholipid Syndrome , 2019, Front. Immunol..
[25] Kerstin B. Meyer,et al. Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.
[26] S. Brennecke,et al. Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines , 2018, Journal of Molecular Medicine.
[27] T. Tuschl,et al. A single-cell survey of the human first-trimester placenta and decidua , 2018, Science Advances.
[28] D. Isenberg,et al. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome , 2018, Journal of autoimmunity.
[29] S. Sciascia,et al. Antiphospholipid syndrome , 2018, Nature Reviews Disease Primers.
[30] G. Mor,et al. The unique immunological and microbial aspects of pregnancy , 2017, Nature Reviews Immunology.
[31] K. Conrad,et al. Emerging role for dysregulated decidualization in the genesis of preeclampsia. , 2017, Placenta.
[32] O. Chazara,et al. Maternal allo-recognition of the fetus. , 2017, Fertility and sterility.
[33] Á. Cadavid. Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications , 2017, Front. Immunol..
[34] Yoon Kyung Choi,et al. Aspirin prevents TNF‐&agr;‐induced endothelial cell dysfunction by regulating the NF‐&kgr;B‐dependent miR‐155/eNOS pathway: Role of a miR‐155/eNOS axis in preeclampsia , 2017, Free radical biology & medicine.
[35] J. Brosens,et al. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. , 2016, Molecular human reproduction.
[36] U. Kayisli,et al. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. , 2016, Human reproduction update.
[37] G. Espinosa,et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. , 2015, Autoimmunity reviews.
[38] L. Chamley,et al. Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature. , 2015, Autoimmunity reviews.
[39] J. Strominger,et al. Immune mechanisms at the maternal-fetal interface: perspectives and challenges , 2015, Nature Immunology.
[40] J. Gris,et al. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. , 2014, Blood.
[41] A. Sharkey,et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. , 2013, The Journal of clinical investigation.
[42] M. Zygmunt,et al. Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB. , 2013, Molecular human reproduction.
[43] Adrian Erlebacher,et al. Immunology of the maternal-fetal interface. , 2013, Annual review of immunology.
[44] Mimi Y. Kim,et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. , 2012, Arthritis and rheumatism.
[45] Pojen P. Chen,et al. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. , 2012, Journal of autoimmunity.
[46] P. Meroni,et al. In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions. , 2011, Blood.
[47] M. Khamashta,et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. , 2011, Blood.
[48] K. McCrae,et al. Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors. , 2011, Blood.
[49] M. Zygmunt,et al. Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ. , 2011, Fertility and sterility.
[50] F. Di Nicuolo,et al. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin. , 2007, Human reproduction update.
[51] L. Poston,et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. , 2006, Placenta.
[52] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[53] D. Ferrara,et al. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. , 2005, Arthritis and rheumatism.
[54] E. Kruithof,et al. Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies , 2004, Journal of thrombosis and haemostasis : JTH.
[55] E. Kruithof,et al. NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 Antibodies , 2002, Thrombosis and Haemostasis.
[56] N. Sebire,et al. Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure , 2002, Lupus.
[57] P. Kaufmann. [Development of human placenta]. , 1971, Zeitschrift fur Geburtshilfe und Gynakologie.
[58] E. Kruithof,et al. NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies. , 2002, Thrombosis and haemostasis.
[59] L. Chamley,et al. Synthesis of beta2 glycoprotein 1 by the human placenta. , 1997, Placenta.